Heartbeam Inc (BEAT) - Total Liabilities
Based on the latest financial reports, Heartbeam Inc (BEAT) has total liabilities worth $3.29 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore BEAT shareholders equity momentum to track the company's year-over-year net asset growth rate.
Heartbeam Inc - Total Liabilities Trend (2003–2025)
This chart illustrates how Heartbeam Inc's total liabilities have evolved over time, based on quarterly financial data. See BEAT cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Heartbeam Inc Competitors by Total Liabilities
The table below lists competitors of Heartbeam Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NORTH PEAK RESOURCES LTD.
F:B9TN
|
Germany | €1.56 Million |
|
Chang Jia M&E Engineering
TWO:4550
|
Taiwan | NT$762.22 Million |
|
Gabriel Resources Ltd
V:GBU
|
Canada | CA$23.73 Million |
|
Tysnes Sparebank
OL:TYSB
|
Norway | Nkr3.23 Billion |
|
Camino Minerals Corporation
V:COR
|
Canada | CA$4.13 Million |
|
Opticis Company Limited
KQ:109080
|
Korea | ₩5.86 Billion |
|
Tons Lightology
TWO:4972
|
Taiwan | NT$378.63 Million |
|
Energía Innovación y Desarrollo Fotovoltaico S.A.
MC:EIDF
|
Spain | €104.09 Million |
Liability Composition Analysis (2003–2025)
This chart breaks down Heartbeam Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Heartbeam Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.84 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Heartbeam Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Heartbeam Inc (2003–2025)
The table below shows the annual total liabilities of Heartbeam Inc from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.24 Million | +99.75% |
| 2024-12-31 | $1.62 Million | +35.85% |
| 2023-12-31 | $1.19 Million | -28.29% |
| 2022-12-31 | $1.67 Million | +183.16% |
| 2021-12-31 | $588.00K | -87.84% |
| 2020-12-31 | $4.84 Million | +29.51% |
| 2019-12-31 | $3.73 Million | -98.65% |
| 2018-12-31 | $276.32 Million | +0.53% |
| 2017-12-31 | $274.86 Million | +357.56% |
| 2016-12-31 | $60.07 Million | +24.58% |
| 2015-12-31 | $48.22 Million | -21.09% |
| 2014-12-31 | $61.10 Million | +194.94% |
| 2013-12-31 | $20.72 Million | +3.52% |
| 2012-12-31 | $20.01 Million | +17.87% |
| 2011-12-31 | $16.98 Million | -21.99% |
| 2010-12-31 | $21.76 Million | +14.73% |
| 2009-12-31 | $18.97 Million | +21.16% |
| 2008-12-31 | $15.66 Million | -87.95% |
| 2007-12-31 | $129.90 Million | +250.84% |
| 2006-12-31 | $37.03 Million | +44.83% |
| 2004-12-31 | $25.57 Million | +80.66% |
| 2003-12-31 | $14.15 Million | -- |
About Heartbeam Inc
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection … Read more